Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Utilization of Human Papillomavirus (HPV) Vaccine Among Young Men Who Have Sex With Men (MSM) and Parents of Boys (Aged 9 to 18 Years)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified July 2011 by Ann & Robert H Lurie Children's Hospital of Chicago.
Recruitment status was:  Recruiting
Sponsor:
Information provided by:
Ann & Robert H Lurie Children's Hospital of Chicago
ClinicalTrials.gov Identifier:
NCT01197079
First received: September 8, 2010
Last updated: July 14, 2011
Last verified: July 2011
  Purpose

The objectives of this study are:

  1. to determine the degree of understanding and perceived risks for human papillomavirus (HPV) disease, to examine and assess attitudes for personal use of HPV vaccine and identify potential barriers to HPV vaccine access and utilization in a population of young men who have sex with men (MSM) (under 26 years of age)and in parents of boys aged 9 to 18 years
  2. to determine HPV vaccine acceptance and predictors of acceptance in a population of young MSM and in patients of boys ages 9 to 18 years
  3. to develop strategies to overcome potential barriers to vaccination and improve vaccine access and utilization via development of targeted educational initiatives.

Condition Intervention
Human Papillomavirus (HPV)
Other: Survey

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Survey Study of the Awareness, Acceptance, and Barriers to Utilization of Human Papillomavirus (HPV) Vaccine Among Young Men Who Have Sex With Men (MSM) and Parents of Boys (Aged 9 to 18 Years)

Further study details as provided by Ann & Robert H Lurie Children's Hospital of Chicago:

Estimated Enrollment: 800
Study Start Date: August 2010
Estimated Study Completion Date: August 2011
Estimated Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
MSM
Young men (under 26 years of age) who have sex with men
Other: Survey
Self administered anonymous survey
Parents
Parents of Boys aged 9 to 18 years
Other: Survey
Self administered anonymous survey

  Eligibility

Ages Eligible for Study:   9 Years to 26 Years   (Child, Adult)
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Young men who have sex with men (MSM) that obtain medical care from a Gay/Lesbian/Bisexual/Transgender community health clinic

Parents of boys aged 9 to 18 years who obtain their medical care from several public health clinics or who obtain their medical care from private pediatrician offices in Chicago

Criteria

Inclusion Criteria:

  • MSM group - under age 26 years
  • Parent group - parent of boy(s) ages 9 to 18 years

Exclusion Criteria:

  • MSM group - previous receipt of HPV vaccine
  • Parent group - previous receipt of HPV vaccine by male child
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01197079

Locations
United States, Illinois
Pediatric Private practice
Chicago, Illinois, United States, 60610
Children's Memorial Hospital Uptown Clinic
Chicago, Illinois, United States, 60640
Pediatric Private Practice
Chicago, Illinois, United States, 60657
Erie Family Health Clinic
Chicago, Illinois, United States
Howard Brown Health Center
Chicago, Illinois, United States
Private pediatric practice
Evanston, Illinois, United States, 60202
Pediatric Private practice
Evanston, Illinois, United States
Sponsors and Collaborators
Ann & Robert H Lurie Children's Hospital of Chicago
  More Information

Responsible Party: Tina Q. Tan, M.D., Children's Memorial Hospital
ClinicalTrials.gov Identifier: NCT01197079     History of Changes
Other Study ID Numbers: Merck IISP 37875 
Study First Received: September 8, 2010
Last Updated: July 14, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by Ann & Robert H Lurie Children's Hospital of Chicago:
HPV
Vaccine
Vaccine utilization
Disease awareness

Additional relevant MeSH terms:
Vaccines
Immunologic Factors
Physiological Effects of Drugs

ClinicalTrials.gov processed this record on December 09, 2016